Home > Company > Media Center > 2011 News Releases/Reports/Presentations
			print     Language English German Date of Publication Title Media Releases Financial Reports Presen-tations 01/25/2012 Lonza Continues its Transformation Towards a Global Life Science Leader 01/05/2012 Presentation Financial Year 2011 Results 12/20/2011 Lonza Launches Novel Plasmid DNA (pDNA) Production Platform 12/15/2011 Lonza to Expand Early Phase Manufacturing Capacity 12/08/2011 Lonza Signs Applied Protein Services Agreement with ImmuneMed 11/18/2011 Change in Visp Site Management 11/15/2011 Lonza Prices CHF 350 Million Dual Tranche Straight Bonds 10/28/2011 Q3 2011 Business Update 10/25/2011 Lonza enters development and manufacturing agreement with Genmab A/S 10/20/2011 Lonza completes acquisition of Arch Chemicals 10/20/2011 Lonza to make trading debut on the Singapore Exchange 10/17/2011 Lonza completes tender offer for Arch Chemicals; announces subsequent offering period 10/11/2011 Lonza announces key partnership with Lipogen for phosphatidylserine 09/30/2011 Arch Chemicals - Lonza extends tender offer to 14 October 2011 09/29/2011 Lonza receives antitrust clearance in France 09/26/2011 Mesoblast and Lonza establish strategic global manufacturing alliance 09/16/2011 Lonza Group Ltd plans secondary listing on the Main Board of the Singapore Stock Exchange 09/15/2011 Lonza enters manufacturing agreement with Pasteuria Bioscience 09/12/2011 Lonza extends tender offer for all outstanding shares of Arch Chemicals common stock to 30 September 2011 09/02/2011 Oxford BioTherapeutics licenses Lonza’s GS Gene Expression System™ 09/01/2011 Lonza celebrates 40 years as leading producer of vitamin B3 08/24/2011 Lonza, JFC Technologies and Novoset LLC announce a strategic collaboration to advance high performance materials offerings 08/19/2011 Lonza to appoint Jeanne Thoma as future COO of the Microbial Control sector 08/11/2011 Lonza extends tender offer for all outstanding shares of Arch Chemicals common stock to 12 September 2011 08/10/2011 Lonza to invest in long-term growing Meta™ metaldehyde business 07/27/2011 Half Year 2011 Results 07/20/2011 Cellectis bioresearch and Lonza achieve significant milestone 07/19/2011 Lonza signs manufacturing deal with IMMUNE Pharmaceuticals for Bertilimumab (iCo-008) 07/15/2011 Lonza commences tender offer to acquire all of the outstanding shares of Arch Chemicals, Inc. for USD 47.20 per share 07/11/2011 Lonza to acquire Arch Chemicals to create the world’s leading Microbial Control business 07/11/2011 Invitations Media- and Analyst/Investor Conferences 07/05/2011 Arbeitszeiterhöhung im Lonza Werk in Visp - Einigung erzielt 06/30/2011 Temporary 43 hour work week instituted to ensure long-term strengthening of Visp site 06/29/2011 Presentation Half Year Results 2011 06/28/2011 Lonza’s New GS System™ Medium and Feed Platform Reaches 10g/L 06/21/2011 Lonza Introduces Light Path™ 06/16/2011 Lonza to refinance revolving credit facility 06/09/2011 Price increases for niacin feed grade and niacinamide feed grade 06/07/2011 Lonza to expand in Singapore 05/18/2011 Lonza to expand viral production capacity 05/12/2011 Lonza to Expand Cytotoxic Manufacturing 04/19/2011 Lonza and ORGANOBALANCE Enter Global License Agreement 04/13/2011 Quarterly Business Update - Q1 2011 04/12/2011 Annual General Meeting of Lonza Group Ltd 04/12/2011 Ordentliche Generalversammlung der Lonza Group AG 04/11/2011 Lonza and Roche enter into MycoTOOL® distribution agreement 03/29/2011 Lonza to invest £16 million to expand its Slough facility 03/21/2011 Invitation to the Annual General Meeting 03/17/2011 Lonza signs agreement with Athera 03/15/2011 Lonza Signs Commercial Manufacturing Deal with Enobia 03/02/2011 Lonza Introduces New Branding 02/08/2011 Kalobios Selects POTELLIGENT® CHOK1SV Cell Line 01/27/2011 Lonza Starts Share Purchase Program 01/26/2011 Financial Year 2010 Results 01/26/2011 Audio Webcast Financial Year 2010 Results 01/05/2011 Lonza Selects IDBS